[Remote] Medical Director, Breast Oncology at Natera

United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, OncologyIndustries

Requirements

M.D. or D.O. degree with board certification in Oncology
At least 5 years of experience in oncology, with a strong background in clinical research and development (strong knowledge in breast cancer preferred)
At least 3 years of clinical trial experience in academia, biotech industry, or equivalent
Associate/full medical director designation commensurate with experience
Strong knowledge in breast cancer, with ability to develop and implement strategies specific to breast oncology (ideal)
Comprehensive knowledge across all histologies and indications in oncology, staying updated on latest advancements
Ability to quickly learn Natera’s technology and competitors', understanding strengths, limitations, and articulating customer value propositions
Proven skill and experience in building and managing a team
Effective written and oral communication skills, with strong persuasive abilities and quick thinking
Project management skills to balance and execute multiple projects simultaneously
Proven team player capable of participating in cross-disciplinary teams
Ability to manage conflict with poise
Strong knowledge of clinical trial methodology, protocol development, regulatory and compliance requirements, statistics, and epidemiology (preferred)

Responsibilities

Collaborate with the Sr. Medical Director, Oncology on the clinical development of ctDNA-based diagnostics
Lead development and implementation of clinical strategies for Natera's oncology products
Oversee medical education and scientific communication for healthcare providers on Natera's oncology offerings
Partner with the commercial team to develop and deliver compelling medical messages for Natera's oncology products
Represent Natera at medical conferences and industry events (in person and virtual)
Foster a culture of scientific excellence and intellectual curiosity within the oncology team
Collaborate with research and development teams on clinical trial design, data analysis, and publication
Provide expert guidance and support on breast oncology cases and clinical trials
Work effectively with cross-functional teams (research, development, commercial, medical affairs) to drive oncology initiatives
Coordinate with internal and external stakeholders to ensure clinical relevance and adoption of Natera’s oncology solutions

Skills

Breast Oncology

ctDNA diagnostics

Clinical Development

Clinical Trials

Medical Education

Scientific Communication

Clinical Trial Design

Data Analysis

Medical Affairs

Cross-Functional Collaboration

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free